Ces scientifiques de l’Université de Californie – Riverside viennent de concevoir un nouveau médicament pour lutter contre le paludisme qui apparaît plus efficace contre les souches résistantes aux mé ...
Ce n’est pas la première mise en garde sur les effets cognitifs négatifs du tabac. Cette recherche menée à l’University College London (UCL) nous explique pourquoi le tabagisme est un facteur majeur ...
LA JOLLA, CA, Sept. 25, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio,” “we,” “our,” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T ...
Vancouver, B.C., Toronto, ON, Sept. 25, 2024 (GLOBE NEWSWIRE) -- On September 30, LifeLabs will pause operations to recognize National Day for Truth and Reconciliation and Orange Shirt Day. This day ...
HAMPTON, N.J., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today new data demonstrating sustained and deepening disease efficacy and a well tolerated safety ...
IRVING, Texas, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Dallas Business Journal has selected U.S. Oral Surgery Management (USOSM) Chief Operations Officer Alisa Ulrey as a 2024 C-Suite Leaders Awards ...
Inauguration of Angelika Amon research building in Vienna Sustainable research building at a cost of EUR 60 million offers modern office and laboratory space Over the past five years, Boehringer’s ...
Selon l’Organisation mondiale de la santé (OMS), plus de 700.000 personnes se suicident chaque année. Pouvoir détecter le risque de suicide reste un défi, et de nombreuses équipes travaillent sur des ...
Acquisition drives Sanner Group’s mission to offer a suite of world leading development and manufacturing services for its customers across the drug delivery and medical device sectors 25 September ...
Résultats cliniques attendus avant la fin de l’année 2024, issus des données cliniques compassionnelles mises à jour et de l’étude pilote PhagoDAIR Demandes d’autorisation d’essai clinique (IND aux ...
BERKELEY HEIGHTS, N.J., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a ...
We are thrilled to provide an update on our efforts to bring our innovative cosmeceutical portfolio to global markets, with the initial launch set for early 2025. The commercialization of our first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback